✦ LIBER ✦

The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

✍ Scribed by Philip O. Livingston; Karen Kaelin; Carl M. Pinsky; Herbert F. Oettgen; Lloyd J. Old

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 626 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19851101)56:9<2194::aid-cncr2820560910>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serological response of melanoma patient

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

✍ Philip O. Livingston; Anthony P. Albino; Tae June C. Chung; Francisco X. Real; A 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

Absence of melanoma specificity in the r

Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines

✍ Peter B. Dent; Shuen-Kuei Liao; Peter B. McCulloch; Barbara R. Stone; Dharam P. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Improved survival of patients with melan

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

✍ Kenneth Miller; Gwen Abeles; Ruth Oratz; Anne Zeleniuch-Jacquotte; Jian Cui; Dan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Induction of systemic CTL responses in m

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: Cessation of CTL responses is associated with disease progression

✍ Mads Hald Andersen; Petra Keikavoussi; Eva-B. Bröcker; Beatrice Schuler-Thurner; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB

Two HLA-A2-positive patients with advanced stage IV melanoma were treated with monocyte-derived dendritic cells (DC) pulsed with either tumor peptide antigens from gp100, MART-1 and MAGE-3 alone or in combination with autologous oncolysates. Clinically, the rapid progression of disease was substanti

Improved survival of patients with stage

Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard

✍ Jack W. Hartley; Dr. William S. Fletcher 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Between 1964 and 1983, 65 patients with Stage I1 extremity melanoma were treated in a nonrandomized fashion with wide local excision, lymph node dissection, and hyperthermic perfusion with 1-phenylalanine mustard at 1.0-1.5 mg/kg. Southwest Oncology Group Stage 11 criteria were used, including IIA

Humoral and cell-mediated immune respons

Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to pha and antigens following immunization

✍ G. C. De Gast; T. H. The; H. Schraffordt Koops; H. A. Huiges; J. Oldhoff; H. O. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB